Subscribe for free to the America First Report newsletter.
Donald Trump has selected John Ratcliffe to lead the Central Intelligence Agency. Ratcliffe’s experience as a member of Congress overseeing the intelligence community and later as director of national intelligence highlighted his readiness to confront the CIA’s abuses of power during the Russia investigation. However, leading the CIA requires more than a strong director; it demands a capable team to implement meaningful reforms.
Drawing on my 19 years of service in the CIA under four presidents and eight directors, I offer insights into how the next director can navigate and reform the entrenched bureaucratic structures often called the “deep state.”
The goal should not be merely to dismantle the deep state but to establish an environment where transparency, accountability, and integrity are the new norms.
History shows that even the most skilled directors can become figureheads without solid backing. When John A. McCone succeeded Allen Dulles in the 1960s, Dulles’ personnel retained control of the agency, keeping McCone in the dark about key activities. More recently, John Brennan’s influence persisted within the CIA under Mike Pompeo’s leadership. Gina Haspel, who served as Pompeo’s deputy and later as director, continued Brennan’s legacy through his surrogates. Brennan had handpicked and groomed Haspel, who reportedly played a key role in assembling the Steele dossier.
To effect real change, the new director must secure organizational support, beginning with the deputy director. The deputy director will play a critical role in complementing Ratcliffe’s vision and overcoming bureaucratic inertia. This position must focus on managing the agency’s operations effectively rather than allowing career civil servants to dictate their will to the director. Appointing the right deputy director is essential for achieving meaningful reform. […]
— Read More: www.theblaze.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
